Medidata Solutions Inc (MDSO) is Downgraded by Wells Fargo to Market Perform

Medidata Solutions Inc (MDSO) was Downgraded by Wells Fargo to ” Market Perform”. Earlier the firm had a rating of “Outperform ” on the company shares. Wells Fargo advised their investors in a research report released on Jul 21, 2016.

Many Wall Street Analysts have commented on Medidata Solutions Inc. Needham Resumed Medidata Solutions Inc on Jul 11, 2016 to “Buy”, Price Target of the shares are set at $55.Medidata Solutions Inc was Downgraded by Jefferies to ” Underperform” on Apr 26, 2016. Medidata Solutions Inc was Initiated by Leerink Partners to “Mkt Perform” on Apr 26, 2016.

On the company’s financial health, Medidata Solutions Inc reported $0.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $0.23. The company had revenue of $114.60 million for the quarter, compared to analysts expectations of $112.38 million. The company’s revenue was up 16.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.22 EPS.

Medidata Solutions Inc opened for trading at $48.13 and hit $54.24 on the upside on Wednesday, eventually ending the session at $53.58, with a gain of 14.66% or 6.85 points. The heightened volatility saw the trading volume jump to 20,90,880 shares. Company has a market cap of $3,070 M.

In a different news, on Jul 13, 2016, Vries Glen Michael De (President) sold 32,500 shares at $49.29 per share price. According to the SEC, on Jul 13, 2016, Tarek Sherif (Chairman & CEO) sold 22,036 shares at $49.24 per share price. On Jul 13, 2016, Steven Isaac Hirschfeld (Vice Chairman) sold 10,000 shares at $49.85 per share price, according to the Form-4 filing with the securities and exchange commission.

Medidata Solutions Inc. (Medidata) provides cloud-based solutions for life sciences. The Company’s solutions are Medidata Rave an electronic data capture (EDC) and clinical data management system (CDMS) solution; Medidata CTMS a clinical trial management solution; Medidata Designer a protocol design tool; Medidata Insights which offer clinical business analytics and metrics; Medidata Balance a randomization and trial supply management solution; Medidata Patient Cloud an electronic patient-reported outcome (ePRO) application; Medidata Grants Manager which develops and manages trial budgets; Medidata contract research organizations (CRO) Contractor an analytics tool; Medidata SQM a set of cloud-based site quality management dashboards; Medidata Coder a medical coding and synonym management solution; Medidata Safety Gateway which collects and transmits events and related data from the EDC system and Medidata Targeted SDV which implements risk-based monitoring strategies.

Medidata Solutions Inc

Leave a Reply

Medidata Solutions Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Medidata Solutions Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.